Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for treating cognitive disorders using 1-benzyl-1-hydroxy-2,3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino-propionic acid amides and related compounds

Methods for treating cognitive disorders using 1-benzyl-1-hydroxy-2,3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino-propionic acid amides and related compounds

US Patent 9314466 · Granted Apr 19, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidaz2022
3,4-disubstituted 3-cyclobutene-1,2-diones and use thereof2021
Sulfur derivatives as chemokine receptor modulators2021
Amide derivatives of N-urea substituted amino acids as formyl peptide receptor l2021
Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory di2021
Use of agonists of formyl peptide receptor 2 for treating dermatological disease2020
Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidaz2020
Use of agonists of formyl peptide receptor 2 for treating dermatological disease2019
Sulfur derivatives as chemokine receptor modulators2019
Method of activating regulatory T cells with alpha-2B adrenergic receptor agonis2019
Method of activating regulatory T cells with alpha-2B adrenergic receptor agonis2019
Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory di2019